newsfilter
← Latest News
PR Newswire·

Immunic Highlights 2025 Accomplishments and Upcoming Milestones

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and...